Showing results (1161-1170 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|December 7, 2006
Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone diseaseRaja S Bobba, Karen Beattie, Bill Parkinson, et al.
Drug Safety|December 7, 2006
Sirolimus-associated proteinuria and renal dysfunctionGopala K Rangan
Drug Safety|March 1, 1992
Effects of estazolam and flurazepam on cardiopulmonary function in patients with chronic obstructive pulmonary diseaseM A Cohn, D D Morris, D Juan
Drug Safety|January 27, 2007
Suicidality and antiepileptic drugs: is there a link?Vladimir V Kalinin
Drug Safety|May 3, 2007
Guidelines for submitting adverse event reports for publicationWilliam N Kelly, Felix M Arellano, Joanne Barnes, et al.
Drug Safety|May 3, 2007
Safety of zafirlukast: results of a postmarketing surveillance study on 7976 patients in EnglandBeverley R Twaites, Lynda V Wilton, Saad A W Shakir
Drug Safety|June 1, 2007
Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom: a review of the literatureLeonard C Hawkins, John N Edwards, Paul I Dargan
Drug Safety|June 1, 2007
Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibaseI Ralph Edwards, Kristina Star, Anne Kiuru
Drug Safety|July 1, 2006
Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?Wolfgang Aichhorn, Alexandra B Whitworth, Elisabeth M Weiss, et al.
Drug Safety|July 1, 2006
Clinical safety of inhaled corticosteroids for asthma in children: an update of long-term trialsSøren Pedersen
Pageof 311